PATH

Seattle, Washington, United States


Purpose

to develop safer, novel, monovalent oral polio vaccines against poliovirus types 1 and 3 for outbreak use

Division

Global Development

Date

November 2017

Region Served

GLOBAL

Committed amount

$93,599,741

Grant topic

Polio

Duration (months)

142

Grantee location

Seattle, Washington, United States

Related work

Polio

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.